Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genetic Technologies Sponsored ADR Representing 30 Ord Shs GENE

Technology Scientific & Technical Instruments
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a... see more

Recent & Breaking News (NDAQ:GENE)

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

GlobeNewswire 16 hours ago

Genetic Technologies Announces $2 Million Registered Direct Offering

GlobeNewswire 4 days ago

New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes

GlobeNewswire 5 days ago

GeneType Clinicians' Adoption Growing - Sales up 5-Fold Year on Year

GlobeNewswire 6 days ago

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire 10 days ago

GTG to pilot GeneType in Breast Screen centers across the U.S.

GlobeNewswire 11 days ago

EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk"

GlobeNewswire April 8, 2024

Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market

GlobeNewswire April 2, 2024

GTG Global Collaborations and Innovation Update

GlobeNewswire March 26, 2024

GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare

GlobeNewswire March 25, 2024

GTG to launch U.S. Customer Digital Media Sales Campaign

GlobeNewswire February 28, 2024

Launching our most comprehensive test and expanding into new global markets

GlobeNewswire January 31, 2024

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire January 5, 2024

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Accesswire December 29, 2023

GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness

GlobeNewswire December 14, 2023

Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change

GlobeNewswire December 12, 2023

Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial

GlobeNewswire October 30, 2023

GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

GlobeNewswire October 18, 2023

Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Accesswire October 6, 2023

GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network

GlobeNewswire September 27, 2023